NIOX Group (NIOX Group) ROE % Adjusted to Book Value : 5.84% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is NIOX Group ROE % Adjusted to Book Value?

NIOX Group's ROE % for the quarter that ended in Dec. 2023 was 17.75%. NIOX Group's PB Ratio for the quarter that ended in Dec. 2023 was 3.04. NIOX Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 5.84%.

NIOX Group ROE % Adjusted to Book Value Historical Data

The historical data trend for NIOX Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group ROE % Adjusted to Book Value Chart

NIOX Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-22.86

2.38

10.30

4.33

NIOX Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															5.88	11.35	8.76	4.30	5.84

Competitive Comparison of NIOX Group's ROE % Adjusted to Book Value

For the Medical Devices subindustry, NIOX Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NIOX Group's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where NIOX Group's ROE % Adjusted to Book Value falls into.

NIOX Group ROE % Adjusted to Book Value Calculation

NIOX Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.16%	/	3.04
	=	4.33%

NIOX Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.75%	/	3.04
	=	5.84%

NIOX Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of NIOX Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

NIOX Group (NIOX Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (OTCPK:CSSPF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

NIOX:UK 82C:Germany

Address

Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB

Website

https://investors.niox.com

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.